Patent & IP news for March 31, 2013

Scaremongering about SEPs from ipfinance.blogspot.com

A post by Stefano Barazza on the IPKat weblog on 11 March caught the attention of Keith Mallinson (WiseHarbor), a regular contributor to IP Finance and a man who has taken a particular interest in ...

Share via E–mail | Twitter | Facebook

En Banc Review in Checkpoint v. All-Tag? from www.patentlyo.com

By Jason Rantanen In December, the Federal Circuit denied a request for rehearing en banc in Highmark v. Allcare Health Management Systems. The request focused on the de novo standard of review that the panel ...

Share via E–mail | Twitter | Facebook

48th Annual Corporate Patent Seminar from www.patentdocs.org

CPS, an ad hoc non-profit association of senior corporate patent professionals dedicated to the effective and healthy exchange of ideas and experiences in the area of intellectual property law and corporate practice, will be holding ...

Share via E–mail | Twitter | Facebook

Conference & CLE Calendar from www.patentdocs.org

April 3-5, 2013 - 28th Annual Intellectual Property Law Conference (American Bar Association (ABA) Section of Intellectual Property Law) - Arlington, VA April 4, 2013 - Inter Partes Review: A 6-Month Check-up (Intellectual Property Owners Association) - 2:00 ...

Share via E–mail | Twitter | Facebook

Court Report from www.patentdocs.org

By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Millennium Pharmaceuticals Inc. v. Fresenius Kabi USA LLC et al. 1:13-cv-00467; filed March 22, 2013 ...

Share via E–mail | Twitter | Facebook

News from Abroad: UK Court of Appeal Upholds Invalidity of Enantiomer Patent from www.patentdocs.org

The "Obvious to Try" Test Is Overused in Assessing Obviousness The UK Court of Appeal Decision in Novartis AG vs Generics (UK) Ltd (trading as Mylan), provides insight into the UK court's approach to ...

Share via E–mail | Twitter | Facebook